SCHEMBL7590106

SCHEMBL7590106

CC(=O)O[C@H](C)CCCCOCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 5/20 0.46
MMP8 P22894 4/20 0.46
MMP9 P14780 3/20 0.46
ALDH1A1 P00352 2/20 0.46
MMP1 P03956 4/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
EPHX2 P34913 1/20 0.41
NAAA Q02083 1/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
ADRB3 P13945 1/20 0.40
TEAD3 Q99594 1/20 0.40
CYP2C19 P33261 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7021705 1.00 MMP3 (0.46) MMP3MMP8MMP9ALDH1A1MMP1
SCHEMBL542708 0.96 ALDH1A1 (0.47) MMP3MMP8MMP9ALDH1A1MMP1
SCHEMBL20581478 0.90 ALDH1A1 (0.50) ALDH1A1HTTSMN1; SMN2CYP2C19TSHR
SCHEMBL20581479 0.90 ALDH1A1 (0.50) ALDH1A1HTTSMN1; SMN2CYP2C19TSHR
SCHEMBL6682726 0.80 NAAA (0.50) ALDH1A1SMN1; SMN2NAAACYP2C19TSHR
SCHEMBL14501881 0.80 ALDH1A1 (0.53) MMP9ALDH1A1TSHR
SCHEMBL27745864 0.80 L3MBTL1 (0.43) MMP3MMP8MMP9ALDH1A1MMP1
SCHEMBL6263485 0.79 MMP3 (0.48) MMP3MMP8MMP9MMP1L3MBTL1
SCHEMBL8879002 0.79 MMP3 (0.49) MMP3MMP8MMP9MMP1L3MBTL1
SCHEMBL15515610 0.79 L3MBTL1 (0.49) MMP3MMP8MMP9MMP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0759915-B1 ASYMMETRIC SYNTHESIS OF CHIRAL SECONDARY ALCOHOLS CELL THERAPEUTICS INC (US) 2002-10-16 EP disclosed
WO-1999033468-A9 METHOD FOR TREATING HYPEROXIA CELL THERAPEUTICS INC (US) 1999-09-23 WO disclosed
WO-1999033468-A1 METHOD FOR TREATING HYPEROXIA CELL THERAPEUTICS, INC. (US) 1999-07-08 WO disclosed
US-5629423-A Asymmetric synthesis of chiral secondary alcohols CELL THERAPEUTICS, INC. (US) 1997-05-13 US disclosed
EP-0759915-A1 ASYMMETRIC SYNTHESIS OF CHIRAL SECONDARY ALCOHOLS CELL THERAPEUTICS, INC. (US) 1997-03-05 EP disclosed
WO-1995031450-A1 ASYMMETRIC SYNTHESIS OF CHIRAL SECONDARY ALCOHOLS CELL THERAPEUTICS, INC. (US) 1995-11-23 WO disclosed